mercredi 6 juillet 2016

Onco Actu du 6 juillet 2016

1. Biologie

Study sheds light on role of mutations in metastasized cancer [MIT News]

2.4 Etiologie - Portables, ondes e-m

ABC Catalyst's future under review after episode linking Wi-Fi and cancer [The Guardian]

3. Prévention

Helpless to Prevent Cancer? Actually, a Lot Is in Your Control [NY Times]

3.1 Tabac

NCI’s Next Decade of Tobacco Control Research [National Cancer Institute]

3.2 Prévention - Obésité

The Urgency in Fighting Childhood Obesity [NY Times]

5. Traitements

New microfluidic device offers means for studying electric field cancer therapy [MIT News]

5.12 Immunothérapies

Immune-based therapy in mice shows promise against pancreatic cancer [WUSTL]

5.2 Pharma

XBiotech Cancer Drug Survival Claim Falls Apart Under Scrutiny [The Street]

5.2.2 Pharma - Fusions & Acquisitions

Bristol-Myers Squibb Boosts Cancer Drug Pipeline with Cormorant Deal [Xconomy]

5.2.3 Pharma - économie

Merck Invests in RNA Startup to Target Cancer [MIT Technology Review]

5.4 Traitements - Economie

Nivolumab for previously treated advanced renal cell carcinoma [NICE]

Nice rejects BMS’ immunotherapy Opdivo for previously treated kidney cancer on pricing [Pharmafile]

5.5.8 ASCO (poumon)

Non-Small Cell and Small Cell Lung Cancers: Immediate Impact of 2016 ASCO Presentations on Clinical Practice [The OBR Blog]

6. Lutte contre les cancers

Stanford Cancer Institute Earns Highest Cancer Center Designation [Scope Blog]

6.6 Publications

First Oncology Society Partnership for New ESMO Open Access Journal [ESMO]

U.K. research charity will self-publish results from its grantees [Science]

Let’s make peer review scientific [Nature News & Comment]